Concepedia

Anna Rasokat

AR

Statistics

Publications

2

Citations

39

H-Index

2

Active since

2024

Affiliations

Düsseldorf University Hospital(Current)

Comprehensive Cancer Center Mainfranken

National Center for Tumor Diseases

Pius Hospital Oldenburg

Heinrich Heine University Düsseldorf

Anna Rasokat is an author at Düsseldorf University Hospital specializing in targeted cancer therapy, chemotherapy, and targeted therapy.

ORCID

Publications per year

2024–2025

2

Publications

2

Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy

Felix Carl Saalfeld, Petros Christopoulos, Carina Wenzel et al. · European Journal of Cancer · 2024 · 23 citations · Full text

, , +17

Treatment Sequences in BRAF-V600–Mutated NSCLC: First-Line Targeted Therapy Versus First-Line (Chemo-) Immunotherapy

Marcel Wiesweg, Ali Alaffas, Anna Rasokat et al. · Journal of Thoracic Oncology · 2025 · 16 citations · Full text

, , +17

1–2 of 2